Pacing Therapies for Vasovagal Syncope

Area of Science:

• Cardiology
• Autonomic Nervous System
• Medical Devices

Background:

• Vasovagal syncope (VVS) involves a cardiac autonomic reflex leading to bradycardia and hypotension.
• Recurrent VVS can be debilitating, necessitating effective intervention beyond non-pharmacological methods.
• Cardioinhibitory VVS, a subtype, presents a specific target for therapeutic strategies.

Purpose of the Study:

• To evaluate the efficacy of permanent cardiac pacing in preventing recurrent cardioinhibitory VVS.
• To determine the optimal pacing strategy, including device type and algorithm, for VVS management.
• To identify key considerations for patient selection, particularly concerning age and long-term risks.

Main Methods:

• Review of available data on permanent pacing for recurrent cardioinhibitory VVS.
• Analysis of the role of bradycardia during the vasovagal reflex in relation to pacing efficacy.
• Consideration of dual-chamber pacemakers with closed-loop stimulation (CLS) algorithms.

Main Results:

• Permanent pacing can be an effective treatment for recurrent cardioinhibitory VVS.
• The success of pacing is contingent on the prominent role of bradycardia during VVS episodes.
• Dual-chamber pacing with CLS appears promising for preventing recurrent cardioinhibitory VVS.

Conclusions:

• Permanent pacing is a viable therapeutic option for select patients with recurrent cardioinhibitory VVS, especially older individuals.
• Caution is advised for younger patients due to potential long-term pacemaker-related complications.
• Further research is needed to clarify the mechanisms of VVS and optimize patient selection criteria for pacing.